Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03862469 · ClinicalTrials.gov registry record · NA
Premenstrual Hormonal and Affective State Evaluation (PHASE) Project
A NA study of Premenstrual Dysphoric Disorder, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 1
- Study location
NCT03862469 is a NA study of Premenstrual Dysphoric Disorder that has completed, run by University of Illinois at Chicago. The registered enrollment target is 129 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03862469, a NA study of Premenstrual Dysphoric Disorder, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
PHASE is designed to evaluate neuroactive hormone trajectories across the menstrual cycle and endocrine, autonomic, and subjective responses to psychosocial stress in women suffering from severe PMS (i.e., premenstrual dysphoric disorder).
Conditions Studied
Interventions
- PROCEDURE Individualized laboratory test
Study Locations (1)
Illinois
- University of Illinois Department of Pharmacy Practice - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2023-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03862469
The ClinicalTrials.gov registry entry for NCT03862469 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Premenstrual Dysphoric Disorder appearing as the primary indexed condition, and to 1 intervention - of which Individualized laboratory test is the first listed.
NCT03862469 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03862469 about?
NCT03862469 is a clinical study titled "Premenstrual Hormonal and Affective State Evaluation (PHASE) Project". PHASE is designed to evaluate neuroactive hormone trajectories across the menstrual cycle and endocrine, autonomic, and subjective responses to psychosocial stress in women suffering from severe PMS (i.e., premenstrual dysphoric disorder).
What is the current status of trial NCT03862469?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2019-09-26. Estimated completion is 2023-09-01.
What conditions does trial NCT03862469 study?
This clinical trial studies the following conditions: Premenstrual Dysphoric Disorder.
What interventions are being tested in trial NCT03862469?
The interventions under investigation include: Individualized laboratory test (PROCEDURE).
Who is sponsoring clinical trial NCT03862469?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03862469 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premenstrual Dysphoric Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.